Palisade Bio (PALI) Total Liabilities (2010 - 2026)

Palisade Bio (PALI) has reported Total Liabilities for 17 consecutive years, with $6.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Total Liabilities rose 108.22% year-over-year to $6.0 million; the TTM figure through Mar 2026 stood at $6.0 million (up 108.22% YoY), while the FY2025 annual figure was $5.0 million, up 46.52% from the prior year.
• Total Liabilities grew to $6.0 million in Q1 2026 per PALI's latest filing, from $5.0 million in the prior quarter.
• Across five years, Total Liabilities topped out at $6.0 million in Q1 2026 and bottomed at $1.5 million in Q1 2023.
• Historically, Total Liabilities has averaged $3.4 million across 5 years, with a median of $3.3 million in 2022.
• On a YoY basis, Total Liabilities climbed as much as 199.97% in 2022 and fell as far as 85.26% in 2022.
• Palisade Bio's Total Liabilities stood at $3.3 million in 2022, then slipped by 16.6% to $2.7 million in 2023, then increased by 23.69% to $3.4 million in 2024, then surged by 46.52% to $5.0 million in 2025, then increased by 19.92% to $6.0 million in 2026.
• Business Quant data shows PALI's Total Liabilities at $6.0 million in Q1 2026, $5.0 million in Q4 2025, and $3.8 million in Q3 2025.